Boston Scientific to buy Intera Oncology, maker of liver cancer treatment

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide more comprehensive cancer treatments.

By Elise Reuter • Nov. 25, 2024

Medtronic buys surgical instrument developer Fortimedix

Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.

By Nick Paul Taylor • Nov. 22, 2024

Henry Schein to acquire medical supplier Acentus

Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.

By Ricky Zipp • Nov. 21, 2024

Boston Scientific closes $3.7B Axonics deal after lengthy review

Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission requested more information.

By Ricky Zipp • Nov. 15, 2024

Tempus AI to buy genetic testing company for $600M

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing business.

By Elise Reuter • Nov. 6, 2024

Boston Scientific continues M&A run with Cortex buy

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ablation devices.

By Ricky Zipp • Nov. 4, 2024

Boston Scientific to close Silk Road Medical headquarters, lay off 138 people

Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in Minnesota.

By Elise Reuter • Oct. 28, 2024

That’s a wrap: 5 takeaways from The Medtech Conference

The conference — Advamed’s largest — featured an appearance by the device center’s new acting director and sessions on AI, clinical trial diversity and the FDA’s contentious LDT rule.

By Elise Reuter • Oct. 22, 2024

Hologic to buy Gynesonics for $350M to acquire fibroid system

Gynesonics’ transcervical system uses ultrasound guidance and radiofrequency energy to ablate fibroids without the need for an incision.

By Nick Paul Taylor • Oct. 15, 2024

5 reasons why MedTech M&A is poised for growth

In spite of uncertainties, the outlook for MedTech M&A is strong. Hint: AI isn’t the (only) factor.

By Caroline Popper, Nemphos Braue LLC • Oct. 7, 2024

Integer sells non-medical business for $50M

After making nearly $550 million worth of acquisitions in the past few years, the medical device contract manufacturer will use proceeds from the sale to pay down debt.

By Susan Kelly • Oct. 2, 2024

What’s next at Masimo after CEO Kiani’s exit?

Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation of its consumer business could play out.

By Susan Kelly • Sept. 30, 2024

Stryker adds devices to remove brain tumors, clots with Nico buy

Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.

By Nick Paul Taylor • Sept. 23, 2024

Masimo proxy fight nears end as shareholder vote looms

Chairman and CEO Joe Kiani’s board seat is on the line at today's shareholder meeting.

By Susan Kelly • Sept. 19, 2024

Merit Medical inks $210M takeover of Cook’s lead management business

Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.

By Nick Paul Taylor • Sept. 18, 2024

Bausch + Lomb considers sale: FT

Private equity could be “the most likely” buyer of the eye care business, analysts wrote.

By Elise Reuter • Sept. 16, 2024

Boston Scientific closes Silk Road Medical acquisition

Completion of the purchase comes three months after the companies announced the deal, and after Boston Scientific resubmitted its merger filing to give the FTC more review time.

By Ricky Zipp • Updated Sept. 17, 2024

Medtech venture investment recovery continues, but startup M&A remains limited: Pitchbook

Acquisitions of late-stage VC startups have been rare, a fact Pitchbook attributed to “ongoing price gaps between buyers and sellers.”

By Nick Paul Taylor • Sept. 4, 2024

Illumina avoids fine for Grail purchase in European court victory

Illumina will avoid a penalty of 432 million euros after a court ruled the European Commission did not have jurisdiction to challenge the company’s Grail acquisition.

By Susan Kelly • Sept. 3, 2024

UFP to buy device component maker AQF Medical, extending deal spree

AQF makes foam and thermoplastic components for use in medical devices and packaging.

By Nick Paul Taylor • Aug. 28, 2024

Siemens Healthineers to grow PET imaging with purchase of Novartis assets

Siemens will pay 200 million euros for the manufacturing and distribution network of Novartis’ radiopharmaceutical molecular imaging business.

By Nick Paul Taylor • Aug. 27, 2024

Getinge to buy Paragonix organ-preserving tech for up to $477M

Getinge will pay $253 million in cash at closing, with additional payments expected to be made between 2024 and 2026 if certain milestones are met.

By Ricky Zipp • Aug. 23, 2024

Quest inks deal for University Hospitals’ outreach lab services

The deal continues Quest’s expansion in Ohio and extends a string of acquisitions that began in May.

By Nick Paul Taylor • Aug. 23, 2024

Stryker to add back pain treatment with Vertos Medical buy

Stryker’s latest purchase comes amid a pickup in medtech M&A, with Johnson & Johnson, Boston Scientific and Edwards Lifesciences all active this year.

By Susan Kelly • Aug. 23, 2024

Zoll to buy Vyaire’s ventilator business with $37M auction bid

Vyaire Medical held a virtual auction of assets after filing for Chapter 11 bankruptcy protection in June.

By Nick Paul Taylor • Aug. 21, 2024